Purpose: To demonstrate the potential of using three-dimensional (3D) sonography to reveal anomalies of fetal skeleton. Materials and Methods: Forty-two normal fetuses and 3 anencephalic fetuses from 14 to 27 weeks’ gestation were studied with a specially developed abdominal 3D transducer (3.5 MHz). This imaging system provided conventional two-dimensional (2D) sonographic images and also generated within seconds high-quality 3D images in the surface and transparent mode with no need for an external workstation. Results: Using this imaging system, we obtained 2D and 3D images of fetal skeleton (skull, scapula, spine, rib, humerus, ulna/radius, pelvis, femur, and tibia/fibra) at two gestational ages. The percentages of fetal skeletal visualization at less than 20 weeks of gestation using 3D sonography were 78–100%, whereas those with 2D sonography were all 100%. The percentages of skeletal structures revealed after 20 weeks’ gestation using 3D sonography were 82–100%, whereas those with 2D sonography were all 100%. We found no significant differences in detection rates of the fetal skeleton between 2D and 3D sonography. However, 3D sonographic images generally provided a more comprehensive view of the fetal skeleton than did conventional 2D sonography. In 2 cases with anencephaly, 3D sonography clearly revealed the defect of cranium. Conclusion: The new 3D sonographic technology can generate within seconds high-quality 3D images of the fetal skeleton. The 3D technology seems to perform at least as well as conventional 2D sonography. Our results suggest that 3D sonography has the potential to supplement 2D sonography and might be useful in identifying malformations of the fetal skeleton and chromosomal abnormalities in utero.

Keywords:
Fetal skeleton, Three-dimensional sonography, Two-dimensional sonography, Anencephalus, Second trimester
This content is only available via PDF.
© 2000 S. Karger AG, Basel
2000
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.